The estimated Net Worth of Juergen Srega is at least $27.8 Milione dollars as of 2 September 2021. Mr. Srega owns over 202,216 units of Bruker Corp stock worth over $8,378,595 and over the last 12 years he sold BRKR stock worth over $18,106,421. In addition, he makes $1,327,860 as President of Bruker CALID Group and Bruker Daltonics Division at Bruker Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Srega BRKR stock SEC Form 4 insiders trading
Juergen has made over 1 trades of the Bruker Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 202,216 units of BRKR stock worth $18,106,421 on 2 September 2021.
The largest trade he's ever made was selling 202,216 units of Bruker Corp stock on 2 September 2021 worth over $18,106,421. On average, Juergen trades about 15,555 units every 0 days since 2013. As of 2 September 2021 he still owns at least 130,936 units of Bruker Corp stock.
You can see the complete history of Mr. Srega stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Juergen Srega biography
Juergen Srega serves as President of Bruker CALID Group and Bruker Daltonics Division of the Company. Mr. Srega has served as President of the Bruker CALID Group since January 2013, with responsibility for management of its global operations. Mr. Srega also serves as a Managing Director of Bruker Daltonik GmbH, an indirect wholly-owned subsidiary of Bruker located in Germany. Prior to joining us, Mr. Srega served since 1996 in a variety of senior management roles at Thermo Fisher Scientific Inc. ("Thermo"), a global provider of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. At Thermo, Mr. Srega led a number of significant operating divisions, including as Vice President and General Manager Biomarkers, BRAHMS GmbH, from 2011 to 2012, Vice President and General Manager Scientific Instruments Division Global Products from 2005 to 2011 and Vice President and General Manager Advanced MS from 1996 to 2004. Prior to 1996, Mr. Srega was with Badenwerk AG, a German power utility company located in Karlsruhe, Germany, from 1988 to 1995 and an employee of Bruker GmbH from 1980 to 1988. Mr. Srega holds a Bachelor of Arts degree in Finance from Nord Akademie in Hamburg, Germany and a Bachelor of Arts degree in Engineering from Karlsruhe University of Applied Science in Karlsruhe, Germany.
What is the salary of Juergen Srega?
As the President of Bruker CALID Group and Bruker Daltonics Division of Bruker Corp, the total compensation of Juergen Srega at Bruker Corp is $1,327,860. There are 2 executives at Bruker Corp getting paid more, with Frank Laukien having the highest compensation of $4,909,640.
How old is Juergen Srega?
Juergen Srega is 65, he's been the President of Bruker CALID Group and Bruker Daltonics Division of Bruker Corp since 2013. There are 3 older and 17 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
What's Juergen Srega's mailing address?
Juergen's mailing address filed with the SEC is BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA, MA, 01821.
Insiders trading at Bruker Corp
Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien e Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.
What does Bruker Corp do?
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
What does Bruker Corp's logo look like?
Complete history of Mr. Srega stock trades at Bruker Corp
Bruker Corp executives and stock owners
Bruker Corp executives and other stock owners filed with the SEC include:
-
Frank Laukien,
Chairman of the Board, President, Chief Executive Officer -
Mark Munch,
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division -
Juergen Srega,
President of Bruker CALID Group and Bruker Daltonics Division -
Gerald Herman,
Chief Financial Officer -
Dr. Frank H. Laukien Ph.D.,
Chairman, CEO & Pres -
Burkhard Prause,
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc -
Falko Busse,
President, Bruker BioSpin Group -
Dr. Mark R. Munch Ph.D.,
Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division -
Juergen Srega,
Pres of Bruker CALID Group & Bruker Daltonics Division -
Gerald N. Herman,
Exec. VP, CFO, Corp. Controller & Interim Head of IR -
Dr. Falko Busse Ph.D.,
Pres of Bruker BioSpin Group -
John Ornell,
Independent Director -
Richard Packer,
Independent Director -
Robert Rosenthal,
Independent Director -
Adelene Perkins,
Independent Director -
William Linton,
Lead Independent Director -
Marc Kastner,
Independent Director -
Hermann Requardt,
Independent Director -
Cynthia Friend,
Independent Director -
Miroslava Minkova,
Director, Investor Relations & Corporate Development -
Bonnie Anderson,
Independent Director -
J. Brent Alldredge J.D.,
Gen. Counsel -
Justin Joseph Ward,
Sr. Director of Investor Relations & Corp. Devel. -
Kristin S. Caplice,
Sec. -
Dr. Burkhard Prause,
Pres and CEO of Bruker Energy & Supercon Technologies, Inc. -
Urban Faeh,
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH -
Stacey Desrochers,
Treasurer & Director of Investor Relations -
Collin J. D'Silva,
Pres of Chemical Analysis Division -
M Christopher Canavan,
Director -
Richard Kniss,
Director -
Ingen Chris Van,
Director -
Stephen W. Fesik,
Director -
Rene Lenggenhager,
President, BioSpin Group -
Anthony L Mattacchione,
Sr VP, Corp Fin & Accounting -
Gilles Gerard Jean Martin,
Director -
Joerg C Laukien,
10% owner -
Michael Gunnar Knell,
Chief Accounting Officer -
Brenda J Furlong,
Director -
Wolf Dieter Emmerich,
Director -
Taylor Crouch,
Director -
Bob Rosenthal,
-
Laura Francis,
Chief Financial Officer -
John Hulburt,
Dir. of Audit /SEC Compliance -
Martin Haase,
Senior Vice President -
Thomas Werner Bachmann,
President Bruker BioSpin Group -
Charles F Jr Wagner,
Director -
Bernhard Wangler,
Director -
Bernd Gewiese,
President, Bruker BioSpin Corp -
Werner Maas,
President, Bruker BioSpin Corp -
Tony Werner Keller,
Director -
Brian P Monahan,
Corporate Controller -
Dirk D Laukien,
10% owner -
Marc M Laukien,
10% owner -
William J Knight,
Chief Financial Officer -
Richard M Stein,
Secretary -
Isolde Laukien,
10% owner -
Collin J Dsilva,
Director -
Philip Ma,